Grandeur Peak Global Advisors, LLC Maxcyte, Inc. Transaction History

Grandeur Peak Global Advisors, LLC

$1.23 Billion
Q1 2024

A detailed history of Grandeur Peak Global Advisors, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Grandeur Peak Global Advisors, LLC holds 250,743 shares of MXCT stock, worth $942,793. This represents 0.09% of its overall portfolio holdings.

Number of Shares

250,743

Previous 656,916 61.83%

Holding current value

$942,793

Previous $3.09 Million 65.99%

% of portfolio

0.09%

Previous 0.22%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.94 - $5.38 $1.6 Million - $2.19 Million	-406,173 Reduced 61.83%	250,743 $1.05 Million
Q4 2023 Feb 13, 2024	SELL	$2.6 - $5.24 $2.02 Million - $4.08 Million	-777,903 Reduced 54.22%	656,916 $3.09 Million
Q3 2023 Nov 14, 2023	BUY	$3.02 - $5.1 $169,938 - $286,982	56,271 Added 4.08%	1,434,819 $4.48 Million
Q2 2023 Aug 14, 2023	BUY	$3.69 - $5.35 $697,646 - $1.01 Million	189,064 Added 15.89%	1,378,548 $6.33 Million
Q1 2023 May 12, 2023	SELL	$4.03 - $5.89 $9,353 - $13,670	-2,321 Reduced 0.19%	1,189,484 $5.89 Million

Q4 2022 Feb 13, 2023	SELL	$4.92 - $7.4 $69,903 - $105,139	-14,208 Reduced 1.18%	1,191,805 $6.51 Million
Q3 2022 Nov 17, 2022	BUY	$4.52 - $6.51 $108,466 - $156,220	23,997 Added 2.03%	1,206,013 $7.84 Million
Q2 2022 Aug 15, 2022	BUY	$3.59 - $6.81 $2.44 Million - $4.63 Million	680,205 Added 135.55%	1,182,016 $5.59 Million
Q1 2022 May 13, 2022	BUY	$5.26 - $10.84 $1.37 Million - $2.82 Million	260,434 Added 107.9%	501,811 $3.51 Million
Q4 2021 Feb 15, 2022	BUY	$8.87 - $12.94 $766,829 - $1.12 Million	86,452 Added 55.8%	241,377 $2.46 Million
Q3 2021 Nov 16, 2021	BUY	$12.21 - $17.2 $1.89 Million - $2.66 Million	154,925 New	154,925 $1.89 Million

Others Institutions Holding MXCT

# of Institutions

126

Shares Held

62M

Call Options Held

2.4K

Put Options Held

2.1K

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $382M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.

Account

Grandeur Peak Global Advisors, LLC Maxcyte, Inc. Transaction History